HomeStock ScreenerDecipher Labs

Decipher Labs Share Price | Decipher Labs Stock Screener

DECIPHER Pharmaceuticals
Share Price BSE
₹7.50
▲ 0.00 (0.00%)
2026-06-03 00:00:00
As of June 3, 2026, the Decipher Labs share price (BSE: DECIPHER) is ₹7.50, unchanged from the previous close, with shares trading between ₹7.16 and ₹7.50, and a 52-week range of ₹5.00–₹11.80. Check DECIPHER 52-week chart for the annual price range and momentum. Use the Decipher Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Decipher Labs Market Cap ₹7.30 Cr.
DECIPHER P/E Ratio (TTM) -0.90
Decipher Labs P/B Ratio 0.38
EPS (TTM) ₹-5.03
Dividend Yield -
Debt to Equity 0.01
DECIPHER 52 Week High ₹11.80
Decipher Labs 52 Week Low ₹5.00
Operating Margin -188.00%
Profit Margin -100.00%
DECIPHER Revenue (TTM) ₹4.00
EBITDA ₹-6.00
Net Income ₹-4.00
Total Assets ₹26.00
Total Equity ₹23.00

Decipher Labs Share Price Chart

Screen Decipher Labs share price with an interactive chart. Analyse DECIPHER price trends and volatility across different timeframes.

Decipher Labs Company Profile - Fundamental Screener

Screen Decipher Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DECIPHER shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE643N01012

Decipher Labs Balance Sheet Screener

Screen DECIPHER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018
Assets
Total Assets 26 34 28 42 39 35 6 3
Current Assets 21 25 20 38 23 23 6 3
Fixed Assets 3 3 3 3 4 5 0 0
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 7 8 2 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 23 22 23 24 14 13 3 2
Share Capital 10 10 10 10 10 10 8 8
Reserves & Surplus 13 12 13 14 4 3 -6 -6

Decipher Labs Income Statement Screener - Profit & Revenue Analysis

Screen Decipher Labs income statement and profit fundamentals. Analyze DECIPHER quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Decipher Labs share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 4 3 4 3 11 8 6 6 10 10 8 8 24 20 15
Expenses 10 6 4 4 9 6 7 6 14 10 10 8 21 13 13
EBITDA -6 -3 0 0 2 2 -1 -1 -4 0 -2 0 3 6 2
Operating Profit % -188.00% -114.00% 3.00% -13.00% 11.00% 18.00% -23.00% -11.00% -39.00% -1.00% -29.00% 2.00% 11.00% -6.00% -7.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -6 -3 0 -1 1 1 -1 -1 -4 0 -2 0 3 6 2
Tax -2 0 0 0 0 0 0 0 0 1 0 0 1 0 0
Net Profit -4 -3 0 -1 1 1 -1 -1 -4 -1 -2 0 2 6 1
EPS -4.07 -3.39 0.02 -0.53 1.19 0.94 -1.31 -0.59 -4.23 -0.94 -1.92 0.01 1.93 5.85 1.18

Decipher Labs Cash Flow Screener - Liquidity Fundamentals

Screen DECIPHER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March
Operating Activities -10 5 -2 8 2 -15 0 0
Investing Activities 3 -2 -4 -1 0 0 0 0
Financing Activities 0 -1 -2 1 4 16 0 0
Net Cash Flow -7 2 -8 8 6 1 0 0

Decipher Labs Shareholding Pattern Screener

See Decipher Labs shareholding pattern with promoter, FII, and DII holdings. Check Decipher Labs promoter holding and ownership changes for DECIPHER on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 78.53% 80.75% 78.76% 78.73% 78.48% 80.43% 80.52% 80.57%
Other Holding 5.04% 2.82% 4.81% 4.84% 5.09% 3.14% 3.05% 3.00%
Shareholder Count 29,596 31,182 30,512 30,174 29,825 33,371 32,833 31,838

Decipher Labs Share Dividend Screener - Share Yield Analysis

Check Decipher Labs dividend history with payout and yield data. View Decipher Labs dividend details including ex-dates and amounts for DECIPHER stock.
No dividends declared by Decipher Labs.

Decipher Labs Stock Index Membership

See which indices include Decipher Labs stock. Check DECIPHER index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Decipher Labs is not part of any tracked indices.
Only major market indices are tracked in our system.

Decipher Labs Market Events Screener - Corporate Actions

Get Decipher Labs corporate actions including splits, bonuses, and buybacks. Check Decipher Labs stock events that may affect DECIPHER share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA 1.45%
Annual General Meeting NA -7.24%
2026-02-12 2026-02-12 Quarterly Result Announcement NA 5.29%
2026-02-12 2026-02-12 Extraordinary General Meeting NA -4.56%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -5.53%
2025-08-14 2025-08-14 Quarterly Result Announcement NA -0.73%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -1.91%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -2.95%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -3.57%
2020-02-12 2020-02-12 Change Of Name NA 0.00%

Decipher Labs Competitors Screener - Peer Comparison

Screen DECIPHER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 442,581 40.42 58,220 6.38% 11,565 54.75
Divis Laboratories 182,828 73.73 10,560 8.73% 2,520 66.48
Torrent Pharmaceuticals 151,833 66.80 13,753 19.18% 2,028 61.90
Cipla 113,025 29.26 27,712 -2.46% 3,783 61.92
Dr Reddys Laboratories 109,105 26.24 33,593 -0.44% 3,998 52.61
Zydus Life Science 104,543 20.40 26,720 13.65% 5,242 69.40
Lupin 104,288 19.46 27,488 19.98% 5,345 47.33
Mankind Pharma 102,351 52.84 14,278 12.03% 1,750 62.34
Aurobindo Pharma 85,000 24.29 33,385 3.21% 3,376 52.91
Laurus Labs 72,530 81.46 6,813 21.03% 884 77.10

Decipher Labs Company Announcements - News Screener

Screen DECIPHER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-22 Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 -
2026-04-21 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-17 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-24 Closure of Trading Window -
2026-02-12 Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025. -
2026-02-12 Board Meeting Outcome for Outcome For Board Meeting Held On 12.02.2026 -
2026-02-12 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-02-12 Shareholder Meeting / Postal Ballot-Outcome of EGM -
2026-02-09 Board Meeting Intimation for Meeting To Be Held On Thursday 12Th February 2026. -
2026-01-21 EXTRA ORDINARY GENERAL MEETING WILL BE HELD ON THURSDAY THE 12TH DAY OF FEBRUARY 2026 AT 11:00 A.M. THROUGH VIDEO CONFERENCING AND OTHER AUDIO-VISUAL MEANS -
2026-01-19 Board Meeting Outcome for For The Meeting Held On 19.01.2026 -
2026-01-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-29 Closure of Trading Window -
2025-11-13 Announcement under Regulation 30 (LODR)-Change in Management -
2025-11-13 Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 -
2025-11-13 Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.11.2025 -
2025-11-10 Board Meeting Intimation for 1. Un-Audited Financial Results And Limited Review Report (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025. 2. Any Other Business With The Permission Of The Chair. -
2025-10-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2025-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -